55 results
8-K
EX-99.1
VANI
Vivani Medical Inc
13 Jun 24
Other Events
8:01am
, which is under development for chronic weight management and demonstrated weight loss comparable to injections of semaglutide, the active ingredient … technology, designed to guarantee medication adherence and improve patient outcomes in the treatment of chronic diseases such as chronic weight management
8-K
EX-99.2
VANI
Vivani Medical Inc
13 May 24
Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results
4:57pm
, biopharmaceutical company developing a portfolio of miniature, long-term, drug implants to treat chronic diseases. Our NanoPortal™ platform technology enables … -1 (exenatide) implants under development for the treatment of chronic weight management in obese or overweight patients and type 2 diabetes
8-K
EX-99.1
VANI
Vivani Medical Inc
13 May 24
Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results
4:57pm
of miniature, long-term GLP-1 implants for the treatment of chronic weight management in obese or overweight patients, type 2 diabetes, and other … chronic diseases
Stable financial position supports operations into the second half of 2025 and potential delivery of key portfolio milestones
Alameda
8-K
EX-99.1
g8kpzu5r7tzrnha4y
26 Mar 24
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
8:31am
8-K
EX-99.2
4fm1lk5
26 Mar 24
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
8:31am
8-K
EX-99.1
x4i pjivr12my
6 Mar 24
Vivani Medical Appoints Daniel Bradbury to its Board of Directors
8:30am
8-K
EX-99.1
seka2w 9ct195x
5 Mar 24
Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants
4:21pm
424B5
n4s8k
5 Mar 24
Prospectus supplement for primary offering
11:31am
8-K
EX-99.2
ekxiqjk
28 Feb 24
Regulation FD Disclosure
8:30am
8-K
kusoq
28 Feb 24
Regulation FD Disclosure
8:30am
8-K
EX-99.1
2dzewm
28 Feb 24
Regulation FD Disclosure
8:30am
8-K
EX-99.1
4cc1 2dnvzcl
14 Nov 23
Results of Operations and Financial Condition
6:06am
8-K
EX-99.2
cxx yczan
14 Nov 23
Results of Operations and Financial Condition
6:06am
8-K
EX-99.1
noosgam
18 Sep 23
Regulation FD Disclosure
6:20am
8-K
EX-99.1
m6svbp 7pbo7r3p
28 Aug 23
Entry into a Material Definitive Agreement
5:43pm